RCT Ventralex vs Onlay Mesh in Incisional Hernias
VPatchIncRCT
Randomised Controlled Trial of Ventralex Versus Onlay Mesh Repair for Midline Incisional Hernias
1 other identifier
interventional
200
1 country
2
Brief Summary
A radomised controlled trial comparing Ventralex patch and Progrip mesh in surgery for midline incisional hernias
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2021
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 19, 2020
CompletedFirst Posted
Study publicly available on registry
April 24, 2020
CompletedStudy Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2027
August 13, 2025
August 1, 2025
5.7 years
April 19, 2020
August 12, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Recurrence rate
Rate of hernia recurrences diagnosed at clinical and/or radiologic examination
One year
Secondary Outcomes (4)
Rate ofntra- and postoperative complications
30 days
Rate of seroma
one year
Persisting postoperative pain
One year
Sick leave
30 days
Study Arms (2)
Ventralex
EXPERIMENTALRepair with Ventralex patch in sublay position
Progrip
ACTIVE COMPARATORRepair with Progrip in Onlay position
Interventions
Eligibility Criteria
You may qualify if:
- Hernia defect 1-4 cm
- Incisional hernia or recurrent hernia after previous primary hernia repair
- BMI \<35
- Age 18-100 years
You may not qualify if:
- Defect size\>4 cm
- Ongoing pregnancy
- BMI\>35
- Primary hernia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Karlskoga Hospital
Karlskoga, Sweden
Karlskoga Hospital
Karlskoga, Sweden
Study Officials
- PRINCIPAL INVESTIGATOR
Gabriel Sandblom, MD
Karolinska Institutet
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The patient and staff responsible for the postoperative care of the patient are masked to the acollcation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
April 19, 2020
First Posted
April 24, 2020
Study Start
January 1, 2021
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
September 30, 2027
Last Updated
August 13, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share